BRPI0410056A - intermediários de imidazopiridina - Google Patents

intermediários de imidazopiridina

Info

Publication number
BRPI0410056A
BRPI0410056A BRPI0410056-5A BRPI0410056A BRPI0410056A BR PI0410056 A BRPI0410056 A BR PI0410056A BR PI0410056 A BRPI0410056 A BR PI0410056A BR PI0410056 A BRPI0410056 A BR PI0410056A
Authority
BR
Brazil
Prior art keywords
imidazopyridine
intermediates
compounds
intermediaries
substituents
Prior art date
Application number
BRPI0410056-5A
Other languages
English (en)
Inventor
Christof Brehm
Wilm Buhr
Peter Jan Zimmermann
M Vittoria Chiesa
Andreas Palmer
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of BRPI0410056A publication Critical patent/BRPI0410056A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"INTERMEDIáRIOS DE IMIDAZOPIRIDINA". A presente invenção refere-se a compostos da fórmula (I), nos quais os substituintes e símbolos têm os significados indicados na descrição. Os compostos são intermediários valiosos para a preparação de compostos farmaceuticamente ativos.
BRPI0410056-5A 2003-05-06 2004-05-04 intermediários de imidazopiridina BRPI0410056A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03010218 2003-05-06
PCT/EP2004/050693 WO2004099203A1 (en) 2003-05-06 2004-05-04 Imidazopyridine intermediates

Publications (1)

Publication Number Publication Date
BRPI0410056A true BRPI0410056A (pt) 2006-05-23

Family

ID=33427041

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410056-5A BRPI0410056A (pt) 2003-05-06 2004-05-04 intermediários de imidazopiridina

Country Status (18)

Country Link
US (1) US7256293B2 (pt)
EP (1) EP1622905A1 (pt)
JP (1) JP2006525285A (pt)
KR (1) KR20060015541A (pt)
CN (1) CN1780834A (pt)
AR (1) AR044129A1 (pt)
AU (1) AU2004235981A1 (pt)
BR (1) BRPI0410056A (pt)
CA (1) CA2524259A1 (pt)
CL (1) CL2004000951A1 (pt)
IS (1) IS8151A (pt)
MX (1) MXPA05011594A (pt)
NO (1) NO20055699L (pt)
PE (1) PE20050149A1 (pt)
RS (1) RS20050811A (pt)
TW (1) TW200504075A (pt)
WO (1) WO2004099203A1 (pt)
ZA (1) ZA200507861B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101312736B1 (ko) 2003-02-27 2013-09-27 팔라우 파르마 에스에이 피라졸로피리딘 유도체
US7470664B2 (en) 2005-07-20 2008-12-30 Merck & Co., Inc. HCV NS3 protease inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6160119A (en) 1997-05-28 2000-12-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Fused dihydropyrans
HRP20020855A2 (en) * 2000-03-29 2004-12-31 Altana Pharma Ag Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders
ATE356131T1 (de) 2000-03-29 2007-03-15 Altana Pharma Ag Tricyclische imidazopyridine
CA2404474A1 (en) 2000-03-29 2001-10-04 Altana Pharma Ag Prodrugs of imidazopyridine derivatives
DE60121345T2 (de) 2000-03-29 2007-07-19 Altana Pharma Ag Alkylierte imidazopyridinderivate
CN1692113A (zh) 2000-10-25 2005-11-02 奥坦纳医药公司 作为胃分泌抑制剂的多取代咪唑并吡啶
US20040235882A1 (en) 2001-08-03 2004-11-25 Jorg Senn-Bilfinger Amino-substituted imidazopyridines for the treatment of gastrointestial diseases
CN1656096A (zh) 2001-08-03 2005-08-17 奥坦纳医药公司 用于治疗胃肠病症的烷基－取代的咪唑吡啶
DK1419163T5 (da) 2001-08-10 2005-12-19 Altana Pharma Ag Tricykliske imidazopyridiner

Also Published As

Publication number Publication date
KR20060015541A (ko) 2006-02-17
WO2004099203A1 (en) 2004-11-18
AR044129A1 (es) 2005-08-24
MXPA05011594A (es) 2005-12-15
ZA200507861B (en) 2008-08-27
TW200504075A (en) 2005-02-01
US7256293B2 (en) 2007-08-14
CN1780834A (zh) 2006-05-31
US20060276499A1 (en) 2006-12-07
CA2524259A1 (en) 2004-11-18
NO20055699L (no) 2006-01-17
WO2004099203A8 (en) 2007-04-26
IS8151A (is) 2005-11-25
CL2004000951A1 (es) 2005-03-04
JP2006525285A (ja) 2006-11-09
NO20055699D0 (no) 2005-12-02
EP1622905A1 (en) 2006-02-08
RS20050811A (sr) 2007-12-31
PE20050149A1 (es) 2005-03-22
AU2004235981A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
BRPI0408347A (pt) derivados de pirimidina
TNSN05007A1 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof.
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
BRPI0207172B8 (pt) pirido-pirimidinas 6-substituída, sua composição e seu uso, bem como seu intermediário
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
SE0201544D0 (sv) Novel compounds and thier use
WO2001082909A3 (de) 2-acyl-indolderivate und deren verwendung als antitumormittel
ATE477256T1 (de) Thienylverbindungen
NO20050088L (no) Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav
ATE345349T1 (de) Purinderivate
BRPI0414948A (pt) derivados de pirazolo-e-imidazo pirimidina
BRPI0415203A (pt) pentanóis reestruturados, um processo para sua produção e seu uso como agentes antiinflamatórios
SE0302546D0 (sv) New compounds
BR0314352A (pt) Indóis 2,7-substituìdos e seu uso como moduladores de 5-ht6
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
SE0203303D0 (sv) Novel Compounds
BRPI0412910A (pt) derivados de nicotinamida úteis como inibidores de pde4
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
SE9904128D0 (sv) Novel compounds
BRPI0410056A (pt) intermediários de imidazopiridina
BRPI0417263A (pt) imidazopiridinas para uso como inibidores de secreção gástrica
BR0214529A (pt) compostos terapêuticos
BR0012329A (pt) Derivados de benzofurano

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.